Innovid Corp.: Nasdaq/NYSE listing notice — Innovid receives NYSE non-compliance notice for stock price below $1.00

Innovid Corp.

NYSE notified Innovid on May 18, 2023 that its average closing stock price was below $1.00 over 30 consecutive trading days.
Company has a six-month cure period to regain compliance by achieving a closing price of at least $1.00.
Possible remedies include a reverse stock split, subject to stockholder approval; no immediate delisting.
NYSE notice does not affect business operations or SEC reporting requirements.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Innovid Corp. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

May 18, 2023, Innovid Corp. (the “Company”) received written notice from the New York Stock Exchange (the "NYSE") that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period. The NYSE notice does not result in the immediate delisting of the Company’s common stock from the NYSE. In accordance with applicable NYSE rules, the Company plans to notify the NYSE that it intends to cure the stock price deficiency and return to compliance with th

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001835378-23-000080

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.